LAB Stock Analysis: Buy, Sell, or Hold?
LAB - Standard BioTools Inc. Common Stock
$0.75
-0.04 (-4.94%)
▼
5d:
-9.46%
30d:
-26.89%
90d:
-20.73%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When LAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LAB is currently trading at $0.75, which is considered oversold relative to its 30-day fair value range of $0.83 to $1.13.
Technical Outlook: Technically, LAB is in a uptrend. The price is currently testing key support at $0.79. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: LAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.55 (+105.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LAB is in a uptrend. The price is currently testing key support at $0.79. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: LAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.55 (+105.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.83 -
$1.13
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding LAB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 105.8% below Wall St target ($1.55)
- CAUTION: 5-day price weakness (-9.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.83 -
$1.13
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.79
Resistance Level
$1.29
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-75.30
Wall Street Target
$1.55
(+105.8%)
Revenue Growth (YoY)
4.6%
Profit Margin
90.7%
Share & Embed Analysis
Last updated: June 24, 2026 6:00 PM ET
Data refreshes hourly during market hours. Next update: 7:00 PM
Data refreshes hourly during market hours. Next update: 7:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced LAB Option Strategies
Professional options setups generated by AI based on today's LAB price and gamma walls.
